Difficulty: Medium
Average Score: 73%
Practice
Commercially available analogs of 1,25-dihydroxyvitamin D3 (calcitriol) are:
Correct answer
C
Rationale
In safety pharmacology across the lifespan, understanding commercially available analogs of 1,25-dihydroxyvitamin D3 (calcitriol) is crucial for healthcare professionals. The correct answer is C) All of the above (A) Doxercalciferol (Hectoral) and (B) Paricalcitol (Zemplar) because both are synthetic analogs of calcitriol used in the treatment of conditions like secondary hyperparathyroidism in patients with chronic kidney disease. These analogs offer advantages like reduced risk of hypercalcemia compared to calcitriol.
Option A, Doxercalciferol, is incorrect because it is a prohormone of calcitriol, not a commercially available analog. Option B, Paricalcitol, is incorrect because it is a selective vitamin D receptor activator, not an analog of calcitriol.
Understanding these analogs is essential for healthcare providers to make informed decisions regarding the appropriate use of vitamin D analogs in patients of different age groups, emphasizing safety considerations and efficacy profiles across the lifespan. This knowledge is critical in optimizing patient outcomes and minimizing adverse effects associated with vitamin D therapy.
Option A, Doxercalciferol, is incorrect because it is a prohormone of calcitriol, not a commercially available analog. Option B, Paricalcitol, is incorrect because it is a selective vitamin D receptor activator, not an analog of calcitriol.
Understanding these analogs is essential for healthcare providers to make informed decisions regarding the appropriate use of vitamin D analogs in patients of different age groups, emphasizing safety considerations and efficacy profiles across the lifespan. This knowledge is critical in optimizing patient outcomes and minimizing adverse effects associated with vitamin D therapy.